Clinical trial
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or…
NCT00003332 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00003332 |
|---|---|
| Title | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer |
| Official title | Phase I/II Study of Induction Chemotherapy With Gemcitabine and Cisplatin Followed by Combined Chemo-radiation and/or Surgical Resection for Locally Advanced Pancreatic Cancer |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, gemcitabine hydrochloride, surgical procedure, radiation therapy |
| Enrollment | 36 |
| Start date | Jul 1, 1997 |
| Primary completion | Oct 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: